Inovio: 'Hold' As Upcoming PDUFA For INO-3107 Is Major Inflection Point [Seeking Alpha]
Precigen, Inc. (PGEN)
Last precigen, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
INO-3107 demonstrated a 72% ORR at year one and 86% at year two, but faces competition from Precigen's PAPZIMEOS and lacks Accelerated Approval status. $58.5 million in cash as of December 31, 2025 was projected to fund operations into Q4 of 2026. Potential pipeline value exists in INO-5412 for GBM, but clinical progress is early and dosing is not expected to happen until 2nd half of 2026. Looking for a portfolio of ideas like this one? Members of Biotech Analysis Central get exclusive access to our subscriber-only portfolios. Learn More » Igor Suka/E+ via Getty Images The last time I spoke about Inovio Pharmaceuticals ( INO ) it was with a Seeking Alpha article entitled " Inovio: Back On Track With INO-3107 BLA For RRP Before End Of 2025 ." With More on my IG service This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm
Show less
Read more
Impact Snapshot
Event Time:
PGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGEN alerts
High impacting Precigen, Inc. news events
Weekly update
A roundup of the hottest topics
PGEN
News
- Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy? [Yahoo! Finance]Yahoo! Finance
- Precigen, Inc. (PGEN) Poised for Growth on Respiratory Papillomatosis Treatment Prospects [Yahoo! Finance]Yahoo! Finance
- Precigen, Inc. (PGEN) Discusses Launch and Differentiation of PAPZIMEOS Immunotherapy for Adult RRP Transcript [Seeking Alpha]Seeking Alpha
- Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat [Yahoo! Finance]Yahoo! Finance
- Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31PR Newswire
PGEN
Earnings
- 3/25/26 - Miss
PGEN
Sec Filings
- 3/31/26 - Form 4
- 3/31/26 - Form SCHEDULE
- 3/30/26 - Form 144
- PGEN's page on the SEC website